Qnity Electronics
This is the archived full research. Read the story
DuPont's former electronics arm: the pads, chemicals and films that chip factories use up as they make and package chips.
The scores
Growth3/4 ↑
Organic volume growth of 20% beating its end markets, but three quarters of record as an independent company caps it below Compounding.
Business quality3/4 →
A qualification barrier stated by a rival who must cross it - but price falls every year, and a named Chinese entrant sells into China.
Financial position3/4 →
Net debt near $3.1 billion against $1.7 billion of guided profit, nothing due before 2032 - but an uncapped indemnification sits beside it.
Execution record3/4 →
Three prints as an independent company, three beats, guidance raised twice. Too short to say more, and the finance seat was interim for seven months.
Per share capture3/4 →
Count falling, buybacks above stock compensation, no convertibles - but six months is a policy rather than a record, and leakage runs through the indemnity.
Potential2/4 ↑
A bigger version of today, and merely expected: no contracted demand at all, and the upside rests on other people's capacity and utilisation decisions.
Risk profile2/4 ↓
A third of sales in China, where one externally controlled rule change resolves in a single step, beside two customers at a fifth.
Valuation3/4 →
About 23.9 times operating profit, 107% of a three-stage value near $109 at an 8% return: fair, inside the 20% margin.
Evidence quality3/4 →
Filings, both reconciliations, the call and three rivals' own annual reports - but the moat's magnitude and half the prize are unmeasured by anyone.
The Verdict
We rate Qnity Neutral. It sells the pads, chemicals and films that chip and circuit-board factories use up every day, and the operating business is doing well, with sales rising on volume alone. But leaving DuPont loaded it with heavy interest costs and an uncapped share of DuPont's old liabilities, so earnings per share fell while sales rose, which makes the business mixed. The price sits about at our value, leaving no room for those liabilities and one-off charges. The gap between adjusted and reported profit narrowing would change the view.
The long caseChips are built taller, with more layers and packaging steps, so factories use more of Qnity's materials per wafer; the shareholder must also keep enough after debt.
How we weighed it
The price against our value
Cuts both ways
Price at 107% of our value
The price is about at our value, with the bear case far below.
The business
Cuts both ways
Mixed
Pads, chemicals and films chip factories use daily, but saddled with debt and old liabilities.
Growth against what the price assumes
In its favour
Sales are rising on volume alone, without help from price.
What could go wrong
Against it
Old liabilities are uncapped, the former parent decides the cases, a third of sales is China and prices drift down.
Against competitors
Cuts both ways
Priced like its named rivals on operating profit.
How its group is behaving
Cuts both ways
It sits in none of our ranked groups; chip production moves it.
The latest news and report
Cuts both ways
The operating business and forecast held, but legacy costs stayed high and reported earnings fell.
The evidence under this - 8 claims
- Half of the excluded charges are intangible amortisation on a filed declining schedule that reaches $89 million by 2030, so the assumption that they stop is partly correct by construction rather than optimistic.
- The cohort is two comparable members on this metric - Entegris is withheld because the vendor's operating margin does not reconcile to its filed XBRL - and a median of two names is one name's opinion, so 'roughly what its rivals fetch' is a weak comparison rather than a strong one.
- Roughly half of the excluded amount is amortisation of intangibles - $102 million in the half - which is non-cash and arises from purchase accounting on acquisitions DuPont made, not from anything Qnity is spending. On a filed schedule it falls from $199 million in 2026 to $89 million in 2030, so the gap narrows mechanically without anything improving.
- The transformation and integration charges inside it, $70 million in the half of which $48 million is information-technology independence, end when the migration completes; management says about two thirds of sites move to Qnity's own systems by the end of 2026.
- 2026-11-04editedre-struck on nine months after the Q3 2026 results: the charges excluded are still two-fifths of adjusted EPS (C66, C68)
The company
Every chip passes through dozens of steps that use up materials: pads and slurries that polish each layer flat, coatings used to print circuit patterns, chemicals that clean and etch, and baths that plate the copper connecting a chip to its package. Qnity sells these.
Over 90% of its 2025 revenue came from products used up in a customer's factory or built into the device. It spent $354M on research in 2025, 7% of sales.
The evidence under this - 2 claims
How it makes money
Customers reorder as their lines run, so sales follow how busy the factories are. Chip-making materials brought in $2.64B in 2025 and circuit-board and packaging materials $2.11B. Samsung was 11% of sales and TSMC 8%, and no customer has signed a long-term commitment to buy.
The evidence under this - 3 claims
Where the money comes from, stream by stream
| Stream | Share of sales (H1 2026) | How it earns it |
|---|---|---|
| Semiconductor Technologies | 53.4% | Consumables used up inside the wafer fab: CMP pads and slurries, cleaning chemistries, lithography and deposition materials, bought per wafer processed. |
| Interconnect Solutions | 46.6% | Plating and metallization chemistry, laminates and Laird thermal and shielding materials built into circuit boards, advanced packages and devices, bought per board or package made. |
Who runs it
Jon Kemp has run Qnity since it left DuPont in November 2025, and ran the same businesses inside DuPont for six years before that. A new finance chief, Ken Rizvi, started in October after nine months with a stand-in. Insiders own less than 1% of the shares. The yearly bonus rides on sales growth and a profit measure taken before interest and DuPont's old liabilities; most share awards ride on how the stock does against other chip stocks.
The evidence under this - 4 claims
- 2026-10-04editedthe seat stayed interim until Rizvi took office on 1 October 2026, not until his appointment in August; the 21 August 2026 8-K (S17) gives the effective date
- No financial metric in either plan is struck below adjusted operating EBITDA, so the interest, indirect legacy costs and transformation charges that separate it from GAAP earnings (C25, C38) cost the plan nothing.
- Relative shareholder return does reach the shareholder's result, and it carries most of the CEO's one-time award.
Why it wins, and who could beat it
Why customers come back
A chip factory approves each material for each step at each generation of chip. Changing supplier means re-proving it on a line whose output is worth far more than the material, to save very little. A rival, MKS, tells its own shareholders that new customers take a long time to approve a supplier.
So customers stay: the average top-ten relationship exceeds thirty years, management says. Each new chip generation is a fresh contest, and advanced chips, about 40% of the portfolio, grew more than 20% in the June quarter.
The evidence under this - 3 claims
- The company publishes no supporting statistic - no retention rate, no win rate, no count of processes of record - and neither do its three listed rivals, so a thirty-year average is an assertion nobody outside can check.
- A long average relationship is also what a concentrated industry looks like regardless of loyalty: there are only four leading-edge logic and memory buyers, so a supplier that survives at all will have a long relationship with each of them.
- There is no filed definition of an advanced node anywhere in Qnity's filings and no filed split on that basis, so both the 40% share and the 20% growth rate rest entirely on management's characterisation of its own mix.
- The comparison against a 7% Investor Day expectation is management's own account of what it told investors ten months earlier, and the Investor Day materials are not in the filings; a beat against a target you also describe is the weakest form of evidence.
The threat
China is 33% of sales, and Chinese factories can buy polishing slurry from a domestic maker, Anji, which Entegris lists beside Qnity as a rival. Qnity itself names five competitors: Entegris, Merck KGaA, Resonac, Element Solutions and MKS.
The evidence under this - 3 claims
The rivals: ENTG, MKSI, ESI, and 2 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | How far along | Priced against it |
|---|---|---|---|
| Anji Microelectronics (Shanghai) Co., LtdPriced against it: Listed abroad | On sale | Listed abroad | |
| ENTG | Entegris Materials SolutionsPriced against it: No usable figure | On sale | No usable figure |
| MKSI | MKS Materials Solutions Division, the former AtotechPriced against it: Yes | On sale | Yes |
| The Japanese resist houses at the EUV layer - JSR, Tokyo Ohka Kogyo, Shin-EtsuPriced against it: Listed abroad | On sale | Listed abroad | |
| ESI | Element SolutionsPriced against it: Yes | On sale | Yes |
How big it could get
How big this could get
The world spent $73.2B on chip materials in 2025: $45.8B in making chips and $27.4B in packaging them. Qnity's $4.75B is a slice of both.
What matters more is how much material each chip uses. Advanced chips take three to five times more per wafer than older ones, management says, and advanced factory capacity is growing about 14% a year to 2028, twice the pace of all capacity.
The evidence under this - 4 claims
- The three-to-five-times multiplier appears nowhere outside Qnity's own annual report. SEMI publishes materials spend and wafer area but no intensity ratio by node, and none of Entegris, MKS or Element Solutions states one.
- The range itself is wide enough to be unfalsifiable: a factor of three and a factor of five imply very different prizes, and the filing gives no basis for choosing within it.
The results
The numbers
Sales grew 18% over the twelve months to Sep 2026, faster than the 9.7% in the year to Dec 2025.
It keeps 11% of sales as profit, down from 13% in the year to Dec 2023.
It keeps 47¢ of each sales dollar after making what it sells, and spends 13¢ of it on selling and admin, its biggest running cost.
Shareholders' money earned 7.2% a year.
It turned 14% of sales into free cash, $777M over the last twelve months.
It owes $2.90B more than the cash it holds, about 2.5 years of the cash its operations bring in.
The share count barely moved in 2.8 years, and pay in shares costs 0.8% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|
| Size and growth | ||||
| Sales | $4.04B | $4.33B | $4.75B | $5.49B |
| Sales growth | - | +7.4% | +9.7% | +18% |
| Profit | ||||
| Gross margin | 43% | 46% | 46% | 47% |
| Net margin | 13% | 17% | 15% | 11% |
| What growth costs, per sales dollar | ||||
| Research and development | 7.5% | 7.2% | 7.4% | 7.0% |
| Selling, general and admin | 13% | 14% | 13% | 13% |
| Pay in shares | 0.3% | 0.3% | 0.4% | 0.8% |
| Capital spending | 5.7% | 4.6% | 6.0% | 6.6% |
| Cash | ||||
| Cash from operations | $882M | $1.06B | $1.27B | $1.14B |
| Free cash flow | $651M | $861M | $988M | $777M |
| Balance sheet | ||||
| Cash and short-term investments | - | $166M | $915M | $1.12B |
| Debt | - | $0 | $4.03B | $4.02B |
| Net cash | - | $166M | −$3.11B | −$2.90B |
| Returns and shares | ||||
| Shares (diluted) | 209M | 209M | 210M | 210M |
What growth costs
Growing has not yet made Qnity more profitable on its operating costs: research, selling and office costs rise about as fast as sales. The gain came earlier, in what the products cost to make. Spending on new plants and on pay in shares is rising faster than sales.
The evidence under this - 2 claims
The years before November 2025 carry DuPont's allocated overheads rather than a standalone company's, which the January 2026 reconciliation puts at about $96 million a year more (C28), so the ratios either side of the spin are struck on different cost bases.
The last report (4 Nov)
Quarter ended September 2026, filed figures.
In the September quarter sales rose 22% to $1.56B, both businesses grew, and Qnity raised its full-year forecast for the third time, to $5.77B to $5.83B of sales.
The shareholder's line again lagged. Reported earnings per share fell 14% to $0.87 as interest and one-off charges rose, DuPont-related costs were $39M, and the forecast implies a weaker December quarter. About two-fifths of nine-month adjusted earnings per share is still left out as charges.
What it did to the thesisIt confirmed the operating business and the raised forecast, but not the closing of the gap between adjusted and reported earnings, which is what our view turns on. DuPont-related costs stayed high and reported earnings fell, so we stay Neutral.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $1.46 against $1.20 expected.
The evidence under this - 5 claims
- The Q3 2025 base is pro forma for the spin-off interest and standalone costs, so the 55% adjusted growth is against a base already reduced by those costs (C30).
- GAAP net income fell to $196M from $223M while sales rose 22%, because interest expense was $64M against $14M and transformation charges $53M against $1M.
- Qnity has beaten and then raised its guide at each of its three prints, so a guide implying a lower December quarter has been conservative before.
- The fourth-quarter figures are our arithmetic on the guide and the nine-month totals, not a number the company states.
- Roughly half of the excluded amount is amortisation of intangibles - $102 million in the half - which is non-cash and arises from purchase accounting on acquisitions DuPont made, not from anything Qnity is spending. On a filed schedule it falls from $199 million in 2026 to $89 million in 2030, so the gap narrows mechanically without anything improving.
- The transformation and integration charges inside it, $70 million in the half of which $48 million is information-technology independence, end when the migration completes; management says about two thirds of sites move to Qnity's own systems by the end of 2026.
- 2026-11-04editedre-struck on nine months after the Q3 2026 results: the charges excluded are still two-fifths of adjusted EPS (C66, C68)
- Management gave a business reason on the call: a seasonal consumer-electronics peak in the third quarter that unwinds in the fourth, plus customer inventory control in the fourth quarter, both of which it describes as its normal pattern.
- The third quarter of 2025 also carried about $40 million of sales pulled forward ahead of a pre-spin systems go-live, which raises the prior-year base rather than lowering the current outlook.
- 2026-11-04editedtested against the Q3 2026 results: the earlier inference of a flat-to-lower fourth quarter held, and is re-struck on the raised guide (C67)
What management did with the money
The $4.1B it borrowed before the spin-off went to DuPont, leaving $4.02B of debt against $961M of cash. Since then it has spent $50M buying back shares and $34M on dividends, holding the share count roughly flat.
The evidence under this - 3 claims
The price, and where we disagree
In short. Fair. The price is about 107% of what we think the business is worth, at an 8% yearly return.
The gap between the two profits is what to watch. Nine-month adjusted earnings of about $3.72 a share leave out about $1.54 of charges. Qnity's share of DuPont's old running costs was $39M in the September quarter after $42M in June, and nothing filed explains the level.
The December-quarter results in late February show where it settles. The raised forecast implies a lower December quarter than September.
The evidence under this - 4 claims
- Roughly half of the excluded amount is amortisation of intangibles - $102 million in the half - which is non-cash and arises from purchase accounting on acquisitions DuPont made, not from anything Qnity is spending. On a filed schedule it falls from $199 million in 2026 to $89 million in 2030, so the gap narrows mechanically without anything improving.
- The transformation and integration charges inside it, $70 million in the half of which $48 million is information-technology independence, end when the migration completes; management says about two thirds of sites move to Qnity's own systems by the end of 2026.
- 2026-11-04editedre-struck on nine months after the Q3 2026 results: the charges excluded are still two-fifths of adjusted EPS (C66, C68)
- 2026-11-04editedQ3 2026 results add $39M for the quarter and $84M for nine months (C68)
- Management gave a business reason on the call: a seasonal consumer-electronics peak in the third quarter that unwinds in the fourth, plus customer inventory control in the fourth quarter, both of which it describes as its normal pattern.
- The third quarter of 2025 also carried about $40 million of sales pulled forward ahead of a pre-spin systems go-live, which raises the prior-year base rather than lowering the current outlook.
- 2026-11-04editedtested against the Q3 2026 results: the earlier inference of a flat-to-lower fourth quarter held, and is re-struck on the raised guide (C67)
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 7.5%, 5.3%, 4.3% | 15.1%, 10.7%, 8.7% | 18.9%, 13.4%, 10.9% |
| Normal operating margin | 21.3% | 26.6% | 29.3% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $53.09 | $109 | $148 |
- Price
- $117
- Priced on
- 6 Nov
- Price as a share of the base value
- 107%
- Starting growth the price pays for
- 16.6%
- Yearly return the price offers on the base case
- 7.8%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $68.32
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 4 Nov 2026; the four quarters to that date. |
| Operating margin today | Data vendor | FMP's income statement, since the filer tags no operating profit line. |
| Tax rate | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 4 Nov 2026; the four quarters to that date. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 31 Dec 2025, filed 26 Feb 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 4 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 4 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 4 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026, 31 Dec 2027, 31 Dec 2028 and 31 Dec 2029: the average of 3 to 7 analysts' revenue estimates, 16.1%, 10.9%, 7.8%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, the average of 7 analysts' estimates, 27.6%, less stock pay of 0.8% of sales: 26.8%, which the base case takes as 26.6%. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 8%, 5% and 4%, the margin settles a fifth lower at 21.3%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 15%, 11% and 9% over three years, the analysts' path (C69), then fades toward 4%, closing 30% of the gap each year; the margin moves to 26.6%, the analysts' year-three figure after stock pay.
Bull caseGrowth runs a quarter above the analysts' path, 19%, 13% and 11%, the margin reaches 29.3%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $97.70 | $122 |
| The normal margin, 15% lower or higher | $91.15 | $127 |
| Capital per dollar of growth, a quarter more or less | $107 | $111 |
| Return on new capital after year ten, at the rate or one step up | $85.44 | $119 |
| The rate, a point higher or lower | $84.72 | $150 |
| Long-run growth a point lower | $97.46 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 21.3% | $67.87 | $76.10 | $85.12 | $94.97 | $106 |
| 23.9% | $77.50 | $86.90 | $97.19 | $108 | $121 |
| 26.6% | $87.14 | $97.70 | $109 | $122 | $136 |
| 29.3% | $96.77 | $108 | $121 | $135 | $151 |
| 31.9% | $106 | $119 | $133 | $149 | $166 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Debt included, buyers pay about 26.5 times Qnity's yearly operating profit, the profit from its business before interest and tax. Its rivals Element Solutions and MKS cost 27.2 and 30.0 times. For the business, that is fair.
The shares cost more: about 44 times last year's reported profit, and 27 times the forecast for the company's own 'adjusted' profit, which leaves out charges worth about two-fifths of it this year.
So the price assumes those charges stop and the old liabilities stay small.
Against its own history. Dearer than its own short record on every measure, most of all on earnings, which the spin-off's interest and old DuPont costs have shrunk.
The evidence under this - 4 claims
- Two of the four quarters in that trailing free cash flow figure - the third and fourth of 2025 - carried little or no interest expense, because the debt was only raised in August and October 2025. The trailing multiple is therefore struck on a cash figure the standalone company will not repeat.
- The trailing price-to-earnings ratio is flattered for the same reason: trailing net income includes the pre-spin third quarter of 2025, which earned $223 million against $136 million in the most recent quarter on 12% more revenue.
- Roughly half of the excluded amount is amortisation of intangibles - $102 million in the half - which is non-cash and arises from purchase accounting on acquisitions DuPont made, not from anything Qnity is spending. On a filed schedule it falls from $199 million in 2026 to $89 million in 2030, so the gap narrows mechanically without anything improving.
- The transformation and integration charges inside it, $70 million in the half of which $48 million is information-technology independence, end when the migration completes; management says about two thirds of sites move to Qnity's own systems by the end of 2026.
- 2026-11-04editedre-struck on nine months after the Q3 2026 results: the charges excluded are still two-fifths of adjusted EPS (C66, C68)
- Half of the excluded charges are intangible amortisation on a filed declining schedule that reaches $89 million by 2030, so the assumption that they stop is partly correct by construction rather than optimistic.
- The cohort is two comparable members on this metric - Entegris is withheld because the vendor's operating margin does not reconcile to its filed XBRL - and a median of two names is one name's opinion, so 'roughly what its rivals fetch' is a weak comparison rather than a strong one.
Priced against its rivals
The competitors its own annual report names, each confirmed against the rival's filing. Measured on company value for each $1 of operating profit, cheapest first:
| Ticker | Company | company value for each $1 of operating profit |
|---|---|---|
| Q | Qnity Electronics | 26.5× |
| ESI | Element Solutions | 27.2× |
| MKSI | MKS | 30.0× |
| ENTG | Entegris held out | not priced |
The middle of the other 2 is 28.6. Qnity Electronics, Inc. is cheapest of 3.
Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.
The cheapest of its named rivals on operating profit, but by too little to mean anything. On this measure it is priced like the group.
Private or foreign rivals that cannot be priced: Merck KGaA (EMD Electronics), Resonac Holdings Corporation.
Where we disagree with the market
A pure bet on AI chip materials: fast growth, high margins, and adjusted earnings per share up 35% this year.
The operating business is as good as advertised. The shareholder's claim on it is two-fifths thinner than the headline earnings say.
All four covering analysts rate it a buy, and none of eight questions on the June call touched the DuPont liabilities or the gap between adjusted and reported earnings.
The gap can close on its own: the write-down of acquired assets falls from $199M this year to $89M by 2030, and the separation work ends. If DuPont's old costs stay near $45M a half, we are too cautious.
What analysts say, and the evidence
The evidence under this - 5 claims
- 2026-11-04editedQ3 2026 results add $39M for the quarter and $84M for nine months (C68)
What could go wrong, and how we would know
The risks
- Uncapped old liabilities. Qnity pays 44% of DuPont's old pollution and closed-business liabilities; the amount it has set aside rose from $190M to $253M in six months.
- No say over the cases. DuPont alone decides how to defend and settle them, and a share held in trust makes that permanent.
- China. A third of sales, with domestic suppliers such as Anji competing for the same factory steps.
- Prices drifting down. Price and product mix have fallen in every year Qnity reports, so growth rests on volume.
- Tied hands until 2027. Tax rules from the spin-off limit acquisitions, share sales and asset sales until November 2027.
The evidence under this - 8 claims
- Part of the increase is mechanical rather than deteriorating: DuPont's recorded liability for future Qualified Spend under the Memorandum of Understanding rose from $185 million to $217 million as spend was incurred, and Qnity's 44% moved with it.
- The Memorandum of Understanding is capped in aggregate at $4 billion of Qualified Spend, of which DuPont bears about $1.4 billion and has already borne roughly $745 million, so this particular obligation has a stated ceiling even though the wider indemnity does not.
What we still do not know
- Why Qnity's share of DuPont's old running costs rose from $3M to $42M in a quarter, and where it settles.
- What the uncapped liabilities will cost in the end. At June the company saw about $100M of reasonably possible exposure above what it had set aside.
The evidence under this - 2 claims
- 2026-11-04editedQ3 2026 results add $39M for the quarter and $84M for nine months (C68)
- Part of the increase is mechanical rather than deteriorating: DuPont's recorded liability for future Qualified Spend under the Memorandum of Understanding rose from $185 million to $217 million as spend was incurred, and Qnity's 44% moved with it.
- The Memorandum of Understanding is capped in aggregate at $4 billion of Qualified Spend, of which DuPont bears about $1.4 billion and has already borne roughly $745 million, so this particular obligation has a stated ceiling even though the wider indemnity does not.
What would change our view
- Neutral→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $87.41, 80% of what we think the business is worth.about ≈$90.56 today, 27% below the last close
- Neutral→UnattractiveThe price runs 20% above fair value
It needs:
- ○The share price rises to about $131, 20% above what we think the business is worth.about ≈$129.73 today, 5% above the last close
- Neutral→AttractiveThe reported and adjusted figures converge
It needs all of:
- ○The adjusted profit margin holds in the high twenties as volumes rise, and the gap between adjusted and reported earnings narrows.checked at the next results, due by 25 Feb
- ○The circuit-board business grows at least as fast as chip materials, with price and mix falling no more than 3% a year.checked at the next results, due by 25 Feb
- Neutral→UnattractiveThe indemnities or China turn
It needs any of:
- ○What Qnity has set aside for DuPont's old liabilities passes $500M.checked at the next results, due by 25 Feb
- ○China falls below a quarter of sales because Qnity loses share there, not because other regions grow faster.checked at the next results, due by 25 Feb
We would also be wrong if
- The circuit-board business grows more slowly than chip materials for two quarters running.
- The adjusted profit margin falls below the high twenties while volumes are still rising.
What is coming
- November 2026 Q3 2026 results: Whether GAAP earnings per share grow for the first time since the spin, where indirect legacy costs settle, and whether fourth-quarter guidance implies a sequential decline.
Every dated event ahead
- November 2026 Q3 2026 results: Whether GAAP earnings per share grow for the first time since the spin, where indirect legacy costs settle, and whether fourth-quarter guidance implies a sequential decline.
- February 2027 Q4 2026 results, FY2026 10-K and 2027 guidance: Full-year sales against the raised $5.55-5.65B range, the year-end legacy accrual against $253M, and whether 2027 guidance keeps the adjusted framing.
- April 2027 2027 proxy statement: The first bonus paid on Qnity's own plan, against which organic sales and adjusted EBITDA goals, and whether any GAAP or cash metric is added.
- November 2027 Tax-free spin restrictions lapse: Whether management turns to acquisitions or share issuance once allowed, the first capital allocation decisions that are wholly its own.
Since we wrote this
- 9 NovThesis reviewStill Neutral: priced at 103% of a value near $114Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits inside the 20% margin of safety.
- 4 NovEarningsSales and guidance beat, but reported earnings still fellSales rose 22% and the forecast went up, yet GAAP EPS fell 14% and DuPont-related costs stayed high. The view holds at Neutral.
- 5 OctThesis reviewThe long case now sits under the verdictAfter the five-name pilot, the owner asked for the long case on every thesis.
- 4 OctThesis reviewOwner's checklist: revenue streams, cost of growth, management, catalystsThe owner's checklist found the method silent on who runs the company, what growth costs, where the money comes from and what is dated ahead; this pass fills those four blocks from the proxy and filings.
- 24 SepNewsNorth Carolina's PFAS claims settled inside the amount Qnity had already set aside. View heldDuPont, Chemours and Corteva settled North Carolina's PFAS claims, and Qnity's share did not move.
- 9 SepThesis writtenNeutral, medium convictionThe operating business grew a fifth in the first half while the shareholder's earnings fell, weighed down by the interest and DuPont liabilities the spin-off attached.
Sources 21
Sources - 21
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-26Item 1 business and product lines, the named competitor list, customer concentration, the geographic split including China at a third of sales, the segment tables, the debt terms and schedule, the amortisation schedule, and Note 15 on the DuPont indemnification, the 44% Applicable Qnity Percentage and the Series A Preferred trustbacksC01C02C03C05C07C11C12C13C14C15C17C19C26C34C35C36C37C39C40C41C43C45C47C63C64
- S02primarycompany filing2026-08-04the statements of operations showing interest expense against a year with none, the balance sheet, the indemnification liabilities at 30 June 2026, the segment reconciliation and the significant-items split by segmentbacksC18C24C25C26C32C37C38C40C42C43C44C46C49C63C64C65
- S03primarycompany filing2026-08-04the full non-GAAP reconciliations, both the Adjusted Earnings and the Adjusted Pro Forma Earnings lines for each year, the adjusted free cash flow bridge, and the raised full-year 2026 guidancebacksC19C20C23C29C53C57
- S04primarytranscript2026-08-04Qnity second quarter 2026 earnings call, 4 August 2026management's stated figures with no filed home - fab utilisation by device type, advanced-node share of portfolio, segment margin ranges, the MSI and PCB growth expectations, the $600 million of capacity investment since 2022; and eight analyst exchanges, none of which touched the legacy indemnification or the GAAP-to-adjusted gap. Note that the 7% Investor Day figure is the analyst Frank Mitsch's phrasing in his question, which management did not dispute rather than stating itself; the 20% advanced-node growth is management's own prepared remark
EUV is important, but not so much in the photoresist layer, but there's a lot of ancillary layers around the photoresist that are really important. ... we talked about at our Investor Day migrating towards getting to be the 50% of -- 45% to 50% of our portfolio would be driven by advanced nodes. And at the track record and the pace that we're on, we'll probably get there early. I think we're kind of exiting here the first half of the year kind of right at 40%. ... our advanced nodes portfolio grew more than 20% during the second quarter. ... I recall at the Investor Day, your expectation was a growth of -- steady growth of around 7% for advanced nodes.
backsC16C21C22C40C51C54 - S05primarycompany filing2026-01-16the carve-out against pro forma reconciliation quantifying the standalone burden - net income of $724M carve-out against $432M pro forma for 2024 - the ~$250M annualised interest figure and the ~$96 million of recurring standalone public-company costsbacksC27C28C55
- S06primarycompany filing2026-02-11a direct rival's own description of the CMP slurry business, and its Materials Solutions competitor column, which names Qnity Electronics and Anji Microelectronics (Shanghai) side by sidebacksC06
- S07primarycompany filing2026-02-24the Materials Solutions Division description of the competing plating chemistry, its statement that customers require lengthy qualification before ordering from a new supplier, and its naming of Qnity as a rivalbacksC04
- S08primarycompany filing2026-02-18the third named rival's own account of the wet plating and circuit-formation chemistry Qnity's Interconnect Solutions sells, and its naming of Qnity among its most significant competitorsread, but no claim rests on it
- S09primaryindustry data2026-05-12the size of the pond, split into wafer fabrication materials of $45.8 billion and packaging materials of $27.4 billion, measured by the industry association rather than by any participant
Global semiconductor materials market revenue increased 6.8% year-over-year to $73.2 billion in 2025 ... Wafer fabrication materials revenue increased 5.4% to $45.8 billion ... Packaging materials revenue grew 9.3% to $27.4 billion in 2025
backsC09 - S10primaryindustry data2026-02-10SEMI Silicon Manufacturers Group, 2025 Annual Worldwide Silicon Wafer Shipments and Revenue Results SEMIthe base unit the whole consumables market is driven by - wafer area processed - and the silicon wafer revenue that has to come out of the pond because Qnity does not make wafers
Worldwide silicon wafer shipments in 2025 increased 5.8% to 12,973 million square inches (MSI) while wafer revenue slipped 1.2% to $11.4 billion.
backsC08 - S11primaryindustry data2025-06-25the rate of the driver measured from outside - advanced process capacity at 7nm and below compounding about 14% a year to 2028 against 7% for total capacity
beginning with 982 thousand wpm in 2025, representing 15% YoY growth ... a historic high of 1.4 million wpm in 2028 ... a CAGR of around 14%, double the industry average ... capacity projected to grow at a compound annual growth rate (CAGR) of 7% from the end of 2024 through 2028
backsC10 - S12primaryvendor data2026-09-09Research pack, frozen at content/Q/research-pack.jsonprice, market capitalisation, enterprise value, the volatility bucket, the analyst split, FINRA short interest, the insider window, the filed-competitor cohort multiples and the segment split read from the filing's own XBRL instancebacksC02C43C44C48C49C50C55
- S13primarycompany filing2026-08-12transaction code P, a genuine open-market purchase of 1,000 shares at $138.136 - read from the raw XML rather than from the pack's aggregatebacksC56
- S14primarycompany filing2025-12-12transaction codes M then S - option exercises at $79.01 followed by same-day sales, both leaving the holder with more shares than before, not the discretionary sales the aggregate reads asbacksC56
- S15primarycompany filing2026-05-12the first raise of 2026 guidance, and the same presentation one quarter earlier - GAAP net income down 19% and GAAP EPS down 22% printed beside Adjusted Earnings up 33%backsC57C58
- S16primarycompany filing2026-04-08the beneficial ownership table as of 10 March 2026, the executive officer biographies, the 2026 annual incentive and long-term incentive design, the December 2025 Transformation Awards and the stock ownership guidelinesbacksC60C61C62
- S17primarycompany filing2026-08-21Rizvi's appointment effective 1 October 2026, his record at Synaptics, Penguin Solutions, UTAC and Isola, his pay package, and Michael Goss's return to principal accounting officerbacksC55C60
- S18primarycompany filing2026-10-04Qnity numbers card, frozen at content/Q/financials.jsonthe filer's own XBRL facts for 2023 to 2025 and the four quarters to June 2026: revenue, cost of sales, R&D, SG&A, stock pay, operating cash flow and capital spendingbacksC63C64
- S19primarycompany release2026-11-04Q3 and nine-month statements of operations, segment sales, the adjusted reconciliations including indirect legacy costs and significant items, adjusted free cash flow, the balance sheet, and the raised 2026 guidance
Qnity is raising full-year guidance based on strong third-quarter performance and continued momentum in the business.
backsC23C38C66C67C68 - S20primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC70
- S21secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC69C70